Overview

Proof of Concept Study to Assess Activity and Safety of SMT C1100 (Ezutromid) in Boys With Duchenne Muscular Dystrophy (DMD)

Status:
Terminated

Trial end date:
2018-09-11

Target enrollment:

Participant gender:

Summary

To Assess the Activity and Safety of SMT C1100 (Ezutromid) in Paediatric Male Participants with Duchenne Muscular Dystrophy (DMD).

Phase:

Phase 2

Details

Lead Sponsor:

Summit Therapeutics